Thermo Fisher Scientific Inc Stock Drops 1.32% with $934 Million Trading Volume Amidst Bullish Analyst Sentiment

On April 21, 2025, Thermo Fisher Scientific Inc. (TMO) experienced a significant decline, with its stock price dropping by 1.32% and a total trading volume of $934 million. This marks the fourth consecutive day of decline, with a cumulative decrease of 6.12% over the past four days.

Analysts have shown a strong bullish sentiment towards Thermo Fisher, with 17 analysts rating the stock as a "Strong Buy" and 14 rating it as a "Buy." Only 3 analysts have given a "Hold" rating, and there are no "Sell" ratings. The average 12-month price target for Thermo Fisher is $624.94, indicating a potential upside of 46.18% from the current price of $427.50. The highest price target is $715.00, while the lowest is $475.00.

Several analysts have highlighted Thermo Fisher's strategic acquisitions and strong financial performance. For instance, Jefferies analyst Tycho Peterson reiterated a "Buy" rating with a price target of $655, citing the company's strategic acquisition that boosts its bioproduction capabilities. Goldman Sachs analyst Matthew Sykes also reiterated a "Buy" rating with a price target of $670, noting the strategic fit of the acquisition and its potential to capture new drugs coming to market.

CMB International Securities analyst Jill Wu reiterated a "Buy" rating with a price target of $690, emphasizing Thermo Fisher's strong Q4 performance and strategic positioning. Scotiabank analyst Sung Ji Nam, however, maintained a "Hold" rating with a price target of $650, acknowledging the company's potential but suggesting a more cautious approach. Raymond James analyst Andrew Cooper reiterated a "Buy" rating with a price target of $667, citing stronger revenues and better adjusted EPS in the fourth quarter of 2024.